Stay updated with breaking news from Dcph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Investment analysts at SVB Leerink increased their Q2 2022 earnings per share estimates for Deciphera Pharmaceuticals in a report issued on Wednesday, May 4th. SVB Leerink analyst A. Berens now forecasts that the company will earn ($0.55) per share for the quarter, up from their previous estimate […]
Equities analysts expect Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) to report earnings of ($0.84) per share for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Deciphera Pharmaceuticals’ earnings. The lowest EPS estimate is ($1.11) and the highest is ($0.61). Deciphera Pharmaceuticals posted earnings per share of ($1.06) during […]
Brokerages predict that Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) will announce sales of $26.82 million for the current quarter, Zacks reports. Seven analysts have provided estimates for Deciphera Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $22.80 million and the highest estimate coming in at $30.00 million. Deciphera Pharmaceuticals reported sales of […]